Why da Re-Fit
Varicose veins: what you see is not the whole story.
The spider veins you can see may be rooted in chronic venous insufficiency you cannot. da Re-Fit treats everything from the deepest saphenous trunks to the finest vessels in the skin — and the reverse is just as true: treating only the deep veins is not enough, because the vessels most linked to your symptoms are often the small ones lying next to sensory nerves. From the deepest vein to the shallowest, and every vessel in between — complete treatment solutions, in one clinic.
The Root Cause
TargetCorrecting reflux in the great & small saphenous veins — the root vessels
Correcting the cause comes first. da Re-Fit offers a full spectrum of first-line treatments, from second-generation thermal ablation (laser EVLT, radiofrequency RFA) to third-generation non-thermal closure (adhesive closure with VenaSeal; mechanochemical ablation — MOCA — with ClariVein and Flebogrif). Surgery is tailored 1:1 to your vessel diameter, anatomy, and immune response — combined into a hybrid procedure when needed.
The Delicate Refinement
TargetMid-size and small vessels beyond surgery; vessels causing symptoms that remain after surgery
Some patients still suffer after surgery — because the vessels causing symptoms are often not the named trunks, but small veins adjacent to sensory nerves. With precision ultrasound that visualizes reflux even in needle-sized vessels, da Re-Fit diagnoses and treats them through ultrasound-guided sclerotherapy, guiding delicate vessel remodeling over time. It is more demanding than Stage 1 — and it is where we excel.
The Future & Aesthetics
TargetSpider veins, lymphatic congestion, dull skin tone of the legs
Medicine once defined varicose disease only by bulging veins; today, evidence is growing that treating spider veins relates to symptom relief. da Re-Fit provides transdermal laser toning and whitening, lymphedema care, and venous-circulation therapy — total leg care grounded in the latest venous pathophysiology, beyond mere aesthetics. This field is still building its evidence base, and we are at its frontier, contributing through research and conference presentations.
